HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alli Campaign Seeks To "Drive Behavior Change," Stresses Healthy Choices

This article was originally published in The Tan Sheet

Executive Summary

GlaxoSmithKline's back-to-the-basics advertising for alli educates consumers about how the weight-loss drug works and the importance of healthy eating and exercise.

You may also be interested in...



GlaxoSmithKline's OTC Garage Sale Includes alli, FiberChoice

GlaxoSmithKline includes the alli weight-loss brand in its planned divestment of international OTCs worth about $813 million in 2010 sales, or 10% of the firm's total Consumer Healthcare business.

Glaxo "Shakes Up" Alli Ad Strategy With New Agency

GlaxoSmithKline's decision to reassign the advertising contract for its alli OTC weight-loss drug two years after the product's launch could point to a fundamental problem with the brand's message, according to Steven Brozak, an investment banker working with biotech, medical device and health care firms

Alli Users Show Self-Motivation Works Best, Side Effects Are “Positive”

Consumers using GlaxoSmithKline's alli OTC weight-loss product in actual use studies that provided the program kit experienced fewer side effects than clinical study participants who did not receive the kit, according to GSK

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS134399

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel